Rustem Uzbekov | Biomedical Sciences | Research Excellence Award

Posted on by The Scientist

Dr. Rustem Uzbekov | Biomedical Sciences | Research Excellence Award

PhD, HDR, IR | Tours University / Moscow University | France

Dr. Rustem E. Uzbekov is a distinguished cell biologist whose research has significantly advanced global understanding of centrosome architecture, centriole biology, and microtubule-based cellular organization. With 3,079 citations, 136 publications, and an h-index of 32, his scholarly record reflects a sustained and influential contribution to the fields of cytology, ultrastructural biology, and cell cycle regulation. Dr. Uzbekov’s work, conducted at Lomonosov Moscow State University, spans a comprehensive exploration of the centrosome—its structure, anomalies, functional dynamics, and its role in human diseases. His extensive body of work includes influential book chapters and editorial contributions that map the historical evolution of centrosome research and highlight emerging frontiers such as insect centrioles and pericentriolar material organization. His strong collaborative footprint—evident through over 340 co-authors—demonstrates his central role in international scientific networks and interdisciplinary cytobiology research. Dr. Uzbekov’s studies provide critical insights into the mechanisms of centrosome splitting, mitotic spindle formation, and microtubule system organization, forming foundational knowledge relevant to cancer biology, developmental defects, and structural cell pathology. With a presence across preprints, co-authored works, and citation-rich publications, his research continues to shape current understanding of cellular ultrastructure and its biomedical implications. Dr. Uzbekov’s academic impact reflects not only scientific rigor and depth but also a strong commitment to advancing cell structural biology at a global scale.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Uzbekov, R. E. (n.d.). Anomalies of the centrosome and its derivatives in human diseases.

  2. Uzbekov, R. E. (n.d.). Structures associated with the centriolar cylinder.

  3. Uzbekov, R. E. (n.d.). Centrosome structure in mitotic cells. [Book chapter].

  4. Uzbekov, R. E. (n.d.). Pericentriolar material and intercentriolar connections: Mechanisms of centrosome splitting and separation.

  5. Uzbekov, R. E. (n.d.). Ultrastructure of the centrioles and basal bodies.

Francesca Esposito | Biomedical Sciences | Excellence in Research

Posted on by The Scientist

Assoc. Prof. Dr. Francesca Esposito | Biomedical Sciences | Excellence in Research

Università di Cagliari | Italy

Dr. Francesca Esposito is a distinguished researcher whose scholarly contributions have significantly advanced the fields associated with her work at the Università degli Studi di Cagliari. Her research excellence is reflected in a strong global academic footprint, supported by 2,349 citations, 92 peer-reviewed documents, and an h-index of 30, underscoring her consistent influence, productivity, and high-impact scholarship. Her publication record demonstrates sustained engagement with complex scientific questions, and her work continues to be widely referenced across multiple disciplines. Throughout her career, Dr. Esposito has built an extensive network of over 400 co-authors, illustrating her strong collaborative capacity and her ability to contribute to interdisciplinary, multicenter, and international research endeavors. This breadth of collaboration highlights her role as a connector within the scientific community and reflects her commitment to advancing collective knowledge. Her research topics span diverse and evolving areas, contributing to both foundational understanding and applied scientific progress. Dr. Esposito’s scholarly output is characterized by methodological rigor, empirical depth, and relevance to societal challenges. Her contributions address critical scientific and technological issues, integrating advanced analytical approaches and innovative frameworks that have strengthened current research paradigms. Her publications consistently appear in reputable journals, signaling the recognition of her work by the broader academic community. Beyond academic metrics, Dr. Esposito’s research has generated meaningful societal impact through its applicability in real-world contexts, informing evidence-based decision-making, guiding technological development, and supporting interdisciplinary innovation. Her academic achievements and sustained research output affirm her position as an influential contributor to contemporary scholarship, advancing scientific knowledge and fostering international research collaboration.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Fulle, M., Marzari, F., Della Corte, V., Fornasier, S., Sierks, H., Rotundi, A., … Esposito, F. (2016). Evolution of the dust size distribution of comet 67P/Churyumov–Gerasimenko from 2.2 AU to perihelion. The Astrophysical Journal, 821(1), 19. Cited by: 225

  2. Formisano, V., Angrilli, F., Arnold, G., Atreya, S., Bianchini, G., Biondi, D., … Esposito, F. (2005). The planetary Fourier spectrometer (PFS) onboard the European Mars Express mission. Planetary and Space Science, 53(10), 963–974. Cited by: 208

  3. Fulle, M., Della Corte, V., Rotundi, A., Weissman, P., Juhasz, A., Szego, K., … Esposito, F. (2015). Density and charge of pristine fluffy particles from comet 67P/Churyumov–Gerasimenko. The Astrophysical Journal Letters, 802(1), L12. Cited by: 189

  4. Rotundi, A., Sierks, H., Della Corte, V., Fulle, M., Gutierrez, P. J., Lara, L., … Esposito, F. (2015). Dust measurements in the coma of comet 67P/Churyumov–Gerasimenko inbound to the Sun. Science, 347(6220), aaa3905. Cited by: 179

  5. Esposito, F., Molinaro, R., Popa, C. I., Molfese, C., Cozzolino, F., Marty, L., … Määttänen, A. (2016). The role of the atmospheric electric field in the dust‐lifting process. Geophysical Research Letters, 43(10), 5501–5508. Cited by: 114

Zhang Guowei | Pharmaceutical Sciences | Excellence in Research

Posted on by The Scientist

Mr. Zhang Guowei | Pharmaceutical Sciences | Excellence in Research

Associate Professor |  Hebei University | China

Dr. Zhang Guowei is an active researcher whose work advances the understanding of psychological health, behavioral patterns, and population-level mental well-being, particularly among young adults in contemporary social environments. His academic influence is demonstrated through 347 citations, 20 publications, and an h-index of 10, reflecting a growing global presence and measurable scholarly impact. His research portfolio integrates empirical analysis, psychometric assessment, and digital-behavior analytics to examine how social, environmental, and technological factors shape mental health outcomes. Dr. Zhang’s contributions include impactful studies on anxiety, depression, insomnia, and PTSD among university students, offering timely insights into evolving psychosocial challenges in the post-pandemic era. His work on time-based online survey patterns and their relationship with offline psychological symptoms provides a novel methodological approach, highlighting his ability to connect digital behavioral traces with real-world psychological states. Through these interdisciplinary inquiries, he addresses urgent public-health concerns and informs evidence-based interventions. With a collaborative network spanning over 70 co-authors, Dr. Zhang actively participates in multi-institutional and cross-regional research efforts. This broad collaborative engagement enhances the robustness of his findings and contributes to the global dialogue on mental health resilience, student well-being, and psychosocial risk assessment. His publications in reputable international journals underscore his commitment to research transparency, open access, and data-driven decision-making. Dr. Zhang’s ongoing work strengthens the academic and societal understanding of mental-health dynamics in rapidly changing environments, emphasizing early detection, preventive strategies, and policy relevance. His scholarly trajectory continues to advance applied psychological research, contributing meaningful evidence to public health systems, educational institutions, and community well-being initiatives worldwide.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Xiong, J.-M., Wang, J.-Y., Liu, Y., … Zhang, G.-W. (2023). Study on prescription medication mode and mechanism of traditional Chinese medicine in the treatment of noncritical COVID-19 based on data mining.

  2. Fu, Z.-T., Wang, J.-Y., Liu, Y., … Zhang, G.-W. (2023). The mechanism of TCM prevention and treatment of heavy COVID-19 based on data mining and network pharmacology.

  3. Zhang, L.-H., Zhang, W.-Y., Xiong, J.-M., … Zhang, G.-W. (2022). Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.

  4. Cui, Q., Ma, Y., Yu, H., … Zhang, G.-W. (2021). Systematic analysis of the mechanism of hydroxysafflor yellow A for treating ischemic stroke based on network pharmacology technology.

  5. Zhang, L., Zhang, W., Xiong, J., … Zhang, G.-W. (2020). Mechanisms of Compound Kushen Injection for treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.

Song-Lin Zhou | Biomedical Sciences | Nanotechnology Innovation Award

Posted on by The Scientist

Dr. Song-Lin Zhou | Biomedical Sciences | Nanotechnology Innovation Award

Research scientist |  School of Tropical Medicine, Hainan Medical University, Haikou, Hainan | China

Dr. Songlin Zhou is a highly productive and influential researcher whose work spans biomedical sciences, network pharmacology, molecular modeling, and bio-nanotechnology. His scholarly contributions demonstrate a sustained commitment to addressing complex medical and biological challenges through integrative, technology-driven approaches. With 576 citations, 37 peer-reviewed publications, and an h-index of 13, Dr. Zhou has established a meaningful presence in the global scientific community. His recent research includes advanced network pharmacology and molecular simulation studies uncovering the mechanisms of therapeutic compounds such as halociline in gastric cancer, as well as pioneering analyses on gut microbial metabolites that elucidate dual-axis pathogenesis in Crohn’s disease. His open-access work on green biosynthesized silver nanoparticles showcases his interdisciplinary strength, contributing to the development of multifunctional hemostatic agents that combine antibacterial, anti-inflammatory, and wound-healing properties. Dr. Zhou’s portfolio reflects wide-ranging international collaboration, with co-authorship across 60 researchers, demonstrating his active engagement in cross-institutional and cross-disciplinary scientific networks. His research not only advances fundamental understanding in disease mechanisms and therapeutic target identification but also supports translational innovation in biomaterials and clinical applications. Through this integrated body of work, Dr. Zhou continues to generate societal impact by contributing to emerging biomedical solutions, strengthening evidence-based therapeutic strategies, and fostering global scientific cooperation.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Chen, S., Li, Y., Liu, J., Wu, J., Zhao, H., Cao, R., & Zhou, S. (2025). Gut microbial metabolite crosstalk in Crohn’s disease: Network pharmacology unveils dual-axis pathogenesis and therapeutic targets. BioFactors.

  2. Li, Y., Tan, Y., Zhao, H., Chen, S., Nilghaz, A., Cao, R., & Zhou, S. (2025). Green biosynthetic silver nanoparticles from Ageratum conyzoides as multifunctional hemostatic agents: Combining hemostasis, antibacterial, and anti-inflammatory properties for effective wound healing. Materials Today Bio, 101468.

  3. Zha, X., Li, Y., Zhao, H., Tan, Y., & Zhou, S. (2024). Pyrrolidine, piperazine, and diazinane alkaloids from the marine bacterium strain Vibrio ruber ZXR-93. Molecules, 29(18), 4446.

  4. Zhang, K., Li, X., Yan, C., Shi, R., Fang, Z., Zhou, S., Cao, R., & Tian, J. (2024). All-wood-based ionic power generator with dual functions for alkaline wastewater reuse and energy harvesting. ACS Nano.

  5. Xu, Z., Zha, X., Ji, R., Zhao, H., & Zhou, S. (2023). Green biosynthesis of silver nanoparticles using aqueous extracts of Ageratum conyzoides and their anti-inflammatory effects. ACS Applied Materials & Interfaces.

Wen-bing Ding | Molecular Biology | Pioneer Researcher Award

Posted on by The Scientist

Prof. Wen-bing Ding | Molecular Biology | Pioneer Researcher Award

College of Plant Protection, Hunan Agricultural University | China

Dr. Wenbing Ding is an accomplished researcher at Hunan Agricultural University whose work has significantly advanced the molecular biology of insect physiology and sustainable pest management. His academic excellence is reflected in his global research influence, with 461 citations, 55 publications, and an h-index of 14, underscoring his growing impact within agricultural biotechnology and entomological sciences. Dr. Ding’s research centers on gene regulation, reproductive pathways, and innovative RNA interference (RNAi)-based strategies targeting major agricultural pests, particularly Chilo suppressalis and Sogatella furcifera. His recent contributions include elucidating the regulatory role of transcription factor E93 in vitellogenesis, demonstrating the reproductive disruption caused by HR3 knockdown, and exploring CRISPR/Cas9-mediated doublesex gene editing to impair fertility and sexual dimorphism advances that collectively strengthen the scientific foundation for next-generation, eco-friendly pest control technologies. Dr. Ding has also contributed to phytochemical research through the characterization of novel heterocyclic pseudoguaianolide derivatives, reflecting the breadth of his scientific versatility. With over 93 co-authors and collaborations across molecular biology, crop protection, and biochemical research communities, his work demonstrates strong interdisciplinary integration and international engagement. His publications across leading journals such as Molecular Biology Reports, Pest Management Science, Insect Biochemistry and Molecular Biology, and Phytochemistry highlight his commitment to high-impact scientific dissemination. Dr. Ding’s research contributes meaningfully to global food security by promoting molecular insights that can be translated into sustainable agricultural practices, reduced pesticide dependency, and enhanced crop resilience. His continued contributions position him as an influential and forward-looking scientist driving innovation at the interface of insect molecular genetics and sustainable pest management.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Ding, W., et al. (2025). Transcription factor E93 regulates vitellogenesis via the vitelline membrane protein 26Ab gene in Chilo suppressalis. Molecular Biology Reports. (Citations: 2)

  2. Ding, W., et al. (2025). Silencing the serine/threonine kinase Akt gene disrupts reproductive physiology in Sogatella furcifera and confers RNAi-mediated insect resistance in rice. Pest Management Science.

  3. Ding, W., et al. (2025). RNA interference knockdown of the nuclear receptor HR3 suppresses vitellogenesis in Chilo suppressalis. Molecular Biology Reports. (Citations: 1)

  4. Ding, W., et al. (2025). Doublesex knockout via CRISPR/Cas9 disrupts fertility and sexual dimorphism of wings in the rice stem borer Chilo suppressalis. Insect Biochemistry and Molecular Biology. (Citations: 0)

  5. Ding, W., et al. (2025). Heterocyclic pseudoguaianolide oligomers and seco-pseudoguaianolide derivatives from the inflorescence of Ambrosia artemisiifolia. Phytochemistry. (Citations: 1)

Caili Ma | Public Health | Research Excellence Award

Posted on by The Scientist

Ms. Caili Ma | Public Health | Research Excellence Award

Head-Nurse | The Second Xiangya Hospital Of Central South University | China 

Dr. Caili Ma is an emerging researcher whose scholarly contributions reflect a focused commitment to advancing evidence-based practice in clinical and nursing sciences. With 67 citations, 8 peer-reviewed publications, and an h-index of 4, Dr. Ma has steadily built a research portfolio that demonstrates both scientific rigor and growing global visibility. Her work spans critical themes in healthcare delivery, professional identity formation, patient-centered care, and stigma reduction within clinical education environments. Notably, her recent randomized controlled trial evaluating the “credit bank” intervention highlights her dedication to designing innovative, measurable strategies that enhance nursing students’ professional identity while addressing the pervasive issue of public stigma an area with significant implications for workforce development, healthcare quality, and long-term professional resilience. Dr. Ma’s collaborative footprint, illustrated by contributions involving more than 50 co-authors, underscores her engagement in interdisciplinary and multicenter research networks, enabling broader translational impact and methodological diversity. Her research influence extends beyond publications, contributing to ongoing discussions in clinical education reform and psychosocial determinants of healthcare performance. Although early in her academic trajectory, her work already demonstrates societal relevance by informing policies and practices aimed at strengthening the nursing workforce, improving mental and professional well-being among trainees, and fostering more inclusive healthcare environments. Through the combination of rigorous study design, collaborative scholarship, and commitment to addressing structural and interpersonal challenges in healthcare systems, Dr. Ma continues to shape a research agenda that aligns with international priorities in health education, stigma reduction, and sustainable professional development. Her growing citation profile and publication output reflect her expanding role in advancing high-quality research that bridges clinical education, behavioral science, and patient-oriented perspectives.

Profiles: Scopus | ORCID 

Featured Publications

  1. Qiu, C., Ni, X., Wang, Y., Cao, M., Li, X., Huang, Z., Chen, Q., Ma, C., & He, Y. (2025). Effects of a “credit bank” intervention on the professional identity and public stigma among nursing students: A randomized controlled trial. Nurse Education Today. Advance online publication. https://doi.org/10.1016/j.nedt.2025.106915     

 

Xue Wu | Cognitive Science | Outstanding Scientist Award

Posted on by The Scientist

Assoc. Prof. Dr. Xue Wu | Cognitive Science | Outstanding Scientist Award

Associate Professor | Peking University | China

Dr. Xue Wu is a highly active and emerging scholar whose research contributions reflect a growing impact in nursing science, healthcare safety, and clinical decision-support systems. With 621 citations, 39 publications, and an h-index of 8, her work demonstrates both productivity and increasing global relevance across interdisciplinary domains. She has contributed to the advancement of cognitive workload assessment, nursing brand development, and predictive modeling for critical care, including the integration of radiology notes and structured clinical data for early ICU readmission risk prediction. Her publications span peer-reviewed journals and collaborative multi-author studies, reflecting strong engagement with diverse research teams—evidenced by collaborations with over 80 co-authors across nursing, medical informatics, and safety management. Dr. Wu’s recent projects, including integrative and scoping reviews on safety-related cognitive workload and professional identity in nursing, reinforce her commitment to strengthening healthcare systems through evidence-based analysis. Her work emphasizes methodological rigor, interdisciplinary synthesis, and the development of tools that enhance patient safety, workforce identity, and clinical outcomes. Through her contributions to predictive analytics and safety frameworks, she supports the transformation of healthcare environments into more adaptive, data-informed, and patient-centered systems. Dr. Xue Wu’s research trajectory continues to contribute meaningfully to the global nursing and healthcare community, advancing knowledge that informs policy, technology design, and clinical practice.

Profiles: Scopus | ResearchGate

Featured Publications

  1. Feng, T., Huang, L., Peng, X., & Wu, X. (2025). An integrative review of cognitive workload assessment for safety management. BMC Nursing.

  2. Ge, H., Hu, H., Li, J., & Wu, X. (2025). Development of a professional profile for enhancing nursing brand image: A scoping review. International Nursing Review.

  3. Hu, H., Ma, L., Ge, H., & Wu, X. (2025). ReAdmit: Predicting early unplanned ICU readmission using radiology notes and structured data. Nursing in Critical Care.

  4. Hu, H., Teng, H., Bai, L., & Wu, X. (2025). Effect of interference on nurses in using nursing information system: A field-based eye tracking study. In Nursing Informatics Research (Book chapter).

  5. Ge, H., Feng, T., Hu, H., & Wu, X. (2025). Profiling learning styles and strategies of nursing students: A cluster analysis study. Nurse Education Today.

Yinfeng Yang | Artificial Intelligence | Research Excellence Award

Posted on by The Scientist

Assoc. Prof. Dr. Yinfeng Yang | Artificial Intelligence | Research Excellence Award

Deputy Director | School of Medical Informatics Engineering, Anhui University of Chinese Medicine | China

Dr. Yinfeng Yang is a distinguished researcher at Anhui University of Chinese Medicine, known for impactful contributions at the interface of traditional Chinese medicine, molecular pharmacology, and bioinformatics-driven disease mechanism analysis. His academic influence is demonstrated by 5,738 citations, 45 publications, and an h-index of 18, underscoring his growing global recognition in biomedical research. Dr. Yang’s work spans cancer biology, immunometabolism, and natural-product-based therapeutics, with recent studies exploring the clinicopathological relevance of BRCA1 in gastric cancer, mitochondrial pathways in rheumatoid arthritis, and angiogenesis-targeting mechanisms of Ginkgo biloba leaves. His research integrates advanced computational tools, systems pharmacology, and machine learning to decode complex biological networks and accelerate drug discovery particularly in ADMET prediction and precision therapeutic strategies. With more than 120 co-authors and interdisciplinary collaborations across oncology, pharmacology, and traditional medicine, Dr. Yang has built a broad scientific network that strengthens the translational potential of his findings. His publications in high-impact journals and open-access platforms contribute to global knowledge accessibility while supporting evidence-based modernization of traditional Chinese medicine. Dr. Yang’s work carries clear societal relevance, offering novel insights for developing safer, more effective treatments for chronic inflammatory diseases and gastrointestinal cancers. His sustained research output and increasing citation impact position him as a valuable contributor to global biomedical innovation and integrative medicine research.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., Li, P., Guo, Z., Tao, W., Yang, Y., … (2014). TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics, 6(1), 13. Cited by: 5,020

  2. Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., & Wang, J. (2022). The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Frontiers in Oncology, 12, 985363. Cited by: 876

  3. Yang, Y., Li, Y., Wang, J., Sun, K., Tao, W., Wang, Z., Xiao, W., Pan, Y., Zhang, S., … (2017). Systematic investigation of Ginkgo biloba leaves for treating cardio-cerebrovascular diseases in an animal model. ACS Chemical Biology, 12(5), 1363–1372. Cited by: 99

  4. Li, Y., Gao, W., Li, F., Wang, J., Zhang, J., Yang, Y., Zhang, S., & Yang, L. (2013). An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine-type CDK2 inhibitors. Molecular BioSystems, 9(9), 2266–2281. Cited by: 53

  5. Li, Y., Wang, J., Xiao, Y., Wang, Y., Chen, S., Yang, Y., Lu, A., & Zhang, S. (2015). A systems pharmacology approach to investigate the mechanisms of action of Semen Strychni and Tripterygium wilfordii Hook F for treatment of rheumatoid arthritis. Journal of Ethnopharmacology, 175, 301–314. Cited by: 51

Yanan Yang | Pharmaceutical Sciences | Research Excellence Award

Posted on by The Scientist

Ms. Yanan Yang | Pharmaceutical Sciences | Research Excellence Award

Student | Tianjin University of Traditional Chinese Medicine | China

Dr. Yanan Yang is a researcher at Tianjin University of Traditional Chinese Medicine, recognized for her contributions at the intersection of gut microbiota, metabolic regulation, and cardiometabolic diseases. Her scholarly influence is demonstrated by 726 citations, 45 peer-reviewed publications, and an h-index of 14, underscoring her growing impact in biomedical and translational health research. Dr. Yang’s work spans gut microbiome dynamics, microbial metabolites, metabolic disorders, traditional Chinese medicine mechanisms, and multi-omics integration. She has contributed to high-visibility studies on acute coronary syndrome, cardiovascular disease mechanisms, type 2 diabetes regulation, and herbal-medicine-induced metabolic modulation. Her involvement in multi-center collaborations—including meta-analyses with large participant cohorts—reflects her ability to bridge clinical findings with microbiome-mediated insights. Dr. Yang’s publications highlight a consistent focus on understanding microbial signatures, therapeutic pathways, and host–microbe interactions to advance preventive and precision medicine. She has also engaged in studies evaluating herbal interventions such as Coptis chinensis, showcasing the integration of traditional medicine with modern biomedical evidence. With over 223 co-authors across her publication record, her collaborative networks extend nationally and internationally, supporting multidisciplinary innovation in gut–heart metabolic axis research. Dr. Yang’s ongoing contributions provide essential foundations for developing microbiome-based diagnostics, therapeutic strategies for metabolic diseases, and evidence-based applications of traditional Chinese medicine, reflecting her role as an emerging and influential scientist in her field.

Featured Publications

  1. Wu, C., Zhao, Y., Zhang, Y., Yang, Y., Su, W., Yang, Y., Sun, L., Zhang, F., Yu, J., … (2022). Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates prediction of BBR’s cholesterol-lowering efficacy in patients. Journal of Advanced Research, 37, 197–208. Cited by: 78

  2. Dong, C., Yang, Y., Wang, Y., Hu, X., Wang, Q., Gao, F., Sun, S., Liu, Q., Li, L., Liu, J., … (2023). Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction compared with stable coronary artery disease. Journal of Advanced Research, 46, 101–112. Cited by: 74

  3. Dong, C., Yu, J., Yang, Y., Zhang, F., Su, W., Fan, Q., Wu, C., & Wu, S. (2021). Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion. Biomedicine & Pharmacotherapy, 139, 111595. Cited by: 74

  4. Yang, Y. N., Wang, Q. C., Xu, W., Yu, J., Zhang, H., & Wu, C. (2022). The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet-induced hyperlipidemia and stimulates liver LDLR expression. Biomedicine & Pharmacotherapy, 155, 113749. Cited by: 60

  5. Xu, W., Yu, J., Yang, Y., Li, Z., Zhang, Y., Zhang, F., Wang, Q., Xie, Y., Zhao, B., & Wu, C. (2023). Strain-level screening of human gut microbes identifies Blautia producta as a new anti-hyperlipidemic probiotic. Gut Microbes, 15(1), 2228045. Cited by: 57